Subhra Mohapatra, PhD, FNAI, FAAAS, FAIMBE
Research Career Scientist
Subhra.Mohapatra@va.gov
Smohapa2@usf.edu
Affiliation(s)
University of South Florida
Professor & Director of the Molecular Medicine Graduate Program, Morsani College of Medicine
Research
Research Area(s): Traumatic brain disease; Respiratory infections; Cancer; Alzheimer’s Disease
Research Population: Rodent models of TBI; Mouse models of respiratory Infections; Mouse models of cancers; Mouse models of Alzheimer’s Disease
Research Methods: Molecular biology; Rodent behavior; Drug delivery; Omics technology
Collaboration
Dr. Mohapatra is Interested in collaborating with clinicians with samples from TBI, respiratory infections, lung cancer and glioblastoma patients.
Connect with Dr. Mohapatra
Recent Funding History
| Dates | Title | Funding Source and Type | Role |
|---|---|---|---|
| 2018-2028 | Salary Support | VA RCS
IK6BX004212 |
PI |
| 2022-2026 | Anti-inflammatory and hMSC Combination Therapy for Traumatic Brain Injury | VA Merit
BX005757 |
PI |
| 2024-2028 | Nanoformulations for Respiratory Infections | VA Merit
BX006456 |
Multiple PI |
| 2024-2029 | Molecular Targets Modulating Neuro COVID Sequelae Linked to Tauopathy | NIH-R01
AG086245 |
PI |
| 2023-2028 | Treatment of Lupus nephritis with nanoparticles that selectively target kidney Glomeruli | NIH-R01
DK134000 |
Co-I |
| 2015-2021 | Nanocarriers Designed to Deliver Nucleic Acids to Brain | NIH-R01
NS095563 |
Co-I |
| 2021-2024 | COVID-19: SARS-CoV-2 Neutralizing Agents | VA Merit
BX005490 |
PI |
| 2017-2022 | Tumor targeted engineered stem cells for treatment of lung cancer | VA Merit
BX003413 |
PI |
| 2017-2021 | Combined Nano and Cell Therapy for the Treatment of TBI | VA Merit
BX002668 |
PI |
| 2017-2021 | Nanomicellar antiviral strategies for RSV infection | VA Merit
BX003685 |
Multiple PI |